FOI Ref: 0055FOI2021

25^th August 2020

Freedom of Information Act 2000 – Request for Information

We are pleased to respond to your request for information and our response is set out below:

Request/ Response

Could you please provide me with the details of any prescribing rebate schemes and QIPP/efficiency saving prescribing schemes active within your CCG for the current financial year 2020-21?

1. Current Primary Care Prescribing Rebate Schemes (19/20)

(Please distinguish which rebates are aligned to Prescqipp and which are independent)

NHS Sheffield CCG had the following rebate agreements in place during 19/20. All schemes were in line with PrescQIPP principles in relation to primary care rebates.

Company	Products
Sandoz	AirFluSal
Sanofi	Apidra
Intrapharm	Aquamax
Aymes	Aymes Complete
Chiesi	Clenil Modulite
Ascensia	Contour Next
Ferring Pharmaceuticals	Firmagon
Merck Serono Limited	Glucophage SR
Sanofi	Insuman
Merck Sharp & Dohme	Januvia
Sanofi	Lantus
Daiichi Sankyo	Lixana
QDEM	Longtec
Sandoz	Mezolar
Ethypharm	Pipexus
Sandoz	Reletrans
Merck Serono Limited	Saizen
GlaxoSmithKline UK Limited	Seretide
Mylan	Sirdupla
Beohringer Ingelhein	Spiolto
Astra Zeneca	Zoladex

2. Which current QIPP Prescribing Schemes 20/21

Name of Scheme     MOT QIPP prescribing efficiencies

Drug(s) covered Glucosamine and chondroitin Azithromycin caps to tabs Barrier Creams Fluoxetine soln to disp tab Metronidazole gel Topiramate caps to tabs Cetirizine caps to tabs Aqueous cream to Epimax GTN sprays Oxycodone  I/R Autoshield to Microdot Cialis to tadalafil Ropinirole to Repinex Salbutamol tabs to soln Nitrofurantoin caps to tabs Tolterodine to Neditol Movicol to Cosmocol Paed Lidocaine plasters Movicol to Cosmocol  Rizatrip oral Lyophil to orodisp Tramadol M/R to Tramulief Cinchocaine to Scheriproct Doxazosin Quetiapine Pen needles Fentanyl patches Dipyridamole Oxycodone M/R Ketone test strips Mesalazine ONS Galantamine Gaviscon advance ISMN Sod Cromogli to Opticrom BGTS1 Rubefacients Aveeno to Epimax oatmeal self-care vitamin D Estriol cream Fora Advanced test strips Co-codamol 8/500 & 15/500 caps to tabs High cost PPIs Buprenorphine

Please note that this is a list of potential opportunities as identified in February 2020. The list would as always be subject to change, depending on the availability of cost saving opportunities that may arise or cease as the year progresses.

3. What is the current years (20/21) CCG QIPP/efficiency savings plan target for your organisation?

The Governing Body originally approved a QIPP plan for 20/21 for £19.5m, however resources to deliver the Plan were diverted to support the COVID response. The CCG is now reviewing recovery arrangements for delivery of QIPP projects.

4. What is the value of the prescribing element for the current year (21/22) CCG QIPP/efficiency savings plan target for your organisation?

Note we have responded for the current year 20/21.

The Governing Body originally approved a QIPP plan for prescribing for 20/21 at £3.45m, however the medicines optimisation team resources to deliver the Plan were diverted to support the COVID response.   The CCG is now reviewing recovery arrangements for delivery of QIPP projects.

5. Does your CCG (or any of its constituent members) use the GP prescribing decision support software known as “DXS” (As can be found here: http://www.dxs-systems.co.uk/)?  Y/N

NHS Sheffield CCG does not use DXS.

NHS Sheffield CCG is not aware of any member practices that use DXS, that would be an individual practice decision and the CCG does not routinely hold that information.